Understanding how patients react to their COVID-19 diagnosis
Patients Reactions Towards Their Diagnosis as Having COVID-19: A Cohort Study
ClinAmygate · NCT04581928
This study looks at how people react to being diagnosed with COVID-19 and how those reactions affect their care and management.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3812 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | ClinAmygate (other) |
| Locations | 1 site (Maadi, Cairo) |
| Trial ID | NCT04581928 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore patients' reactions to being diagnosed with COVID-19 and how these reactions impact their management and care. It will investigate various factors that influence patients' responses and identify potential obstacles and barriers to effective management. By analyzing these reactions, the study seeks to provide insights into improving patient care and addressing the challenges faced by individuals diagnosed with COVID-19.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 years or younger who have been diagnosed with COVID-19.
Not a fit: Patients with mental health conditions that hinder communication may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of patient experiences and improve management strategies for COVID-19.
How similar studies have performed: While there have been studies on patient reactions to various diagnoses, this specific focus on COVID-19 reactions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * COVID-19 * Age 18 years of less Exclusion Criteria: * Mental diseases making the communication with them difficult
Where this trial is running
Maadi, Cairo
- Asalam — Maadi, Cairo, Egypt (RECRUITING)
Study contacts
- Principal investigator: Emad R Issak, MD — Assalam Clinics
- Study coordinator: Emad R Issak, MD
- Email: dr.emad.r.h.issak@gmail.com
- Phone: 01272228989
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Covid19